Medtronic's Kappa 700 pacer to offer ease-of-use advantages over recently introduced Kappa 400.
This article was originally published in The Gray Sheet
Executive Summary
MEDTRONIC KAPPA 700 PACEMAKER PHYSICIAN EASE OF USE COULD BE KEY SELLING POINT to doctors unfamiliar and/or uncomfortable with high-tech features offered by next-generation pacemakers, Mario Talejic, MD, University of Montreal, and a clinical investigator of the Kappa 700 suggested. Speaking at a Feb. 3 session of the Piper Jaffray medical device conference in New York City, Talejic said that the Kappa 700 also is intended to streamline implant procedures and reduce the amount of time needed for patient follow-up.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.